Lv5
1030 积分 2023-09-01 加入
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
1个月前
已完结
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases
1个月前
已完结
Rapid and durable response to fifth-line lorlatinib plus olaparib in an ALK -rearranged, BRCA2-mutated metastatic lung adenocarcinoma patient with critical tracheal stenosis: a case report
1个月前
已完结
Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis
1个月前
已完结
Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors
1个月前
已完结
Human Insecurity and Mental Health Among Young Nigerien IDPs: a Qualitative Exploration of the Role of Quality of Life as a Risk and Protective Factor
2个月前
已完结
In Their Own Words: Mental Health and Quality of Life of West African Refugees in Nigeria
2个月前
已完结
The Use of Artificial Intelligence in Lung Cancer Management
2个月前
已完结
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
3个月前
已完结
皖公网安备34019202002308
